PhRMA v. David
District Court: Eastern District of California Status: Decided
PhRMA challenged California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, and …
Pharmaceutical Care Management Association (PCMA) v. Rutledge
District Court: Eastern District of Arkansas Status: Decided
Act 900 (SB 688), enacted in 2015, required disclosure of generic drug pricing and sets a floor on prices that PBMs can pay to pharmacies …
In re Express Scripts/Anthem ERISA Litigation
District Court: Southern District of New York Status: Pending
The district court dismissed a proposed class action against Anthem Inc. and Express Scripts Inc. over drug pricing methods, holding that the companies can’t be …
Alcon Labs., Inc. v. Cottrell
District Court: District of New Jersey Status: Decided
Consumers brought putative class action against manufacturers and distributors of prescription eye medication, alleging they packaged medication in such a way as to force consumers …
Drogueria Betances LLC v. Novartis Pharmaceuticals Corp.
District Court: Southern District of New York Status: Pending
Novartis Pharmaceuticals Corp. allegedly agreed with Par Pharmaceuticals Inc. to squelch generic competition to Novartis’s hypertension drug Exforge, resulting in buyers paying millions more than …
Federal Trade Commission v. AbbVie Inc. et al.
District Court: Eastern District of Pennsylvania Status: Decided
FTC alleged AbbVie sued generic companies for patent infringement over their proposed generic version of the testosterone gel, AndroGel, without justifiable grounds but merely to …
In the Matter of Impax Laboratories Inc.
District Court: Federal Trade Commission Status: Pending
The Federal Trade Commission sued generic drugmaker Impax Laboratories Inc. for allegedly accepting more than $100 million to delay its release of a generic version …
In re: EPIPEN (Epinephrine Injection, USP) Marketing, Sales Practices, and Antitrust Litigtion
District Court: District of Kansas Status: Pending
The plaintiffs in the case allege Mylan N.V. created and exploited an EpiPen monopoly by providing aggressive rebates and incentives to pharmacy benefit managers to …
Sentry Data Sys. v. CVS Health
District Court: S.D. Florida Status: Pending
340B administrator Sentry Data Systems sued CVS pharmacy alleging that since CVS aquired Wellpartner, the company has engaged in unlawful tying, using its status as …
RxStrategies v. CVS Pharmacy
District Court: M.D. Florida Status: Pending
340B administrator RxStrategies sued CVS pharmacy alleging that since CVS aquired Wellpartner, the company has engaged in unlawful tying, using its status as a “must …
In re: Suboxone Antitrust Litigation (State of Wisconsin, et al. v. Indivior Inc, et al.)
District Court: E.D. Pennsylvania Status: Pending
In September 2016, 35 state attorneys general and the District of Columbia brought a multi-district case against pharmaceutical manufacturer Indivior, MonoSol RX et al., alleging …
Shire US, Inc. v. Allergan, Inc. et al.
District Court: District of New Jersey Status: Pending
On October 2, 2017, Shire filed a complaint in New Jersey district court accusing Allergan of violating federal and state antitrust laws by improperly discounting …